199. Receptor Desensitization

×

Receptor Desensitization

This simulation models the molecular mechanisms by which G protein-coupled receptors (GPCRs) become desensitized following prolonged agonist exposure, a process critical for preventing signal overload and maintaining cellular homeostasis.

The Desensitization Cascade

• Receptor Activation: Agonist binding induces conformational change, enabling G-protein coupling and cAMP signaling
• GRK Phosphorylation: G protein-coupled receptor kinases (GRK2/3 and GRK5/6) phosphorylate activated receptors at multiple C-terminal serine/threonine residues
• β-Arrestin Binding: Phosphorylation increases receptor affinity for β-arrestins, which sterically block G-protein coupling (homologous desensitization)
• Clathrin-Mediated Endocytosis: β-arrestins scaffold with clathrin and AP-2, stabilizing clathrin-coated pits that invaginate and pinch off via dynamin

GRK Isoform Specificity

Different GRK isoforms have distinct functional consequences:

• GRK2/3: Bulk phosphorylation enabling β-arrestin binding and internalization
• GRK5/6: Phosphorylation enabling β-arrestin-dependent ERK activation without promoting robust internalization

Three Desensitization Regimes

Recent kinetic modeling (2024) identified three distinct regimes determined by the balance between:

• Phosphorylation rate (GRK activity)
• Dephosphorylation rate (phosphatase activity)
• Cellular β-arrestin concentration

Receptor Fate

• Rapid Recycling: Receptors return to plasma membrane within minutes (Class A pattern)
• Slow Recycling: Extended endosomal residence before recycling (Class B pattern)
• Degradation: Lysosomal targeting leads to receptor downregulation

Clinical Relevance

Receptor desensitization underlies drug tolerance (e.g., opioid tolerance requires multisite phosphorylation), and β-arrestin dysfunction is implicated in neurodegenerative diseases including Alzheimer's and Parkinson's disease.